Business & Finance

CollaGenex Pharmaceuticals agrees to sell U.K. and European dental assets

Published in Drug Week, November 26th, 2004

CollaGenex International, Ltd., the wholly owned U.K. subsidiary of CollaGenex Pharmaceuticals, Inc., (CGPI), has agreed to sell the rights to its U.K. and European dental assets to Alliance Pharma, plc, a U.K. specialty-pharmaceutical company, for $3.3 million.

These assets primarily consist of the use of trademarks, U.K. and European governmental marketing authorizations, distribution agreements, and other intangible assets relating to the sale of Periostat in the U.K. and Europe. Sales of Periostat in the U.K. and Europe were approximately $560,000 for the year ended December 31, 2003. The sale of its U.K. and European dental assets reflects a strategic decision by...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2004-11-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry